Remove 2011 Remove Pharma Remove Physicians Remove Prescription
article thumbnail

Voice is Becoming the Loudest Tool in the Exam Room

PM360

The line from the 2011 Pixar “Cars” sequel (trust me, as a parent of two, I have seen it countless times) points to the practical implication for voice technology. Health systems are signing off on network-wide solutions that use AI companions to record conversations, compile EHR notes, and even order tests and prescriptions.

article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Figure 1: Share of net spending for specialty and traditional prescription medications. The Uses—and Costs—of Specialty Treatments Keep Rising A U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. And he’s also a Pharma Marketing Network Editorial Advisory Board member. At the moment, it started off with, you know, five 8 10 million in 2011. Do you think that that’s happening within pharma now? I’ll be your host today.

Pharma 52
article thumbnail

Ep. 003 – Ritesh Patel Podcast Transcript

Pharma Marketing Network

RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. And he’s also a Pharma Marketing Network Editorial Advisory Board member. At the moment, it started off with, you know, five 8 10 million in 2011. Do you think that that’s happening within pharma now? I’ll be your host today.

Pharma 40
article thumbnail

Healthcare stories in the news

World of DTC Marketing

Democrats have been campaigning for 30 years on promises they’d let Medicare directly negotiate the cost of prescription drugs. Now, after the majority of voters want reduced costs for their prescription drugs, the bill seems ready to pass despite record pharma lobbying. And those trends have only accelerated into 2022.